Richards Timothy T. 4
4 · ClearPoint Neuro, Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
ClearPoint (CLPT) Director Timothy T. Richards Receives 442-Share Award
What Happened Timothy T. Richards, a director of ClearPoint Neuro, acquired 442 shares on April 1, 2026 as an award/other acquisition (transaction code A). The shares were issued at $9.10 each for a total value of $4,022 and were granted as payment of director fees rather than an open-market purchase.
Key Details
- Transaction date and price: 2026-04-01, 442 shares at $9.10 per share (total $4,022).
- Transaction type: A = Award/other acquisition (shares issued as compensation).
- Source/footnote: Shares issued under the Sixth Amended and Restated 2013 Incentive Compensation Plan in payment of fees under the Non-Employee Director Compensation Plan; issued at the issuer’s closing price on March 31, 2026.
- Shares owned after transaction: Not disclosed in this filing.
- Timeliness: Form 4 filed April 2, 2026 for a 2026-04-01 transaction (appears timely; Form 4s are generally due within two business days).
Context This was an equity compensation award for director fees, not an open-market purchase or sale. Such awards are routine corporate compensation and do not necessarily indicate the director’s personal trading intent.
Insider Transaction Report
Form 4
Richards Timothy T.
Director
Transactions
- Award
Common Stock
[F1]2026-04-01$9.10/sh+442$4,022→ 80,196 total
Footnotes (1)
- [F1]These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026.
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Timothy T. Richards|2026-04-02